Jf. Norman et Cw. Miller, PROSTACYCLIN, THROMBOXANE A(2), AND ATHEROSCLEROSIS IN YOUNG HYPERCHOLESTEROLEMIC SWINE, Prostaglandins, leukotrienes and essential fatty acids, 51(4), 1994, pp. 293-298
Plasma 6-keto-prostaglandin F-1 alpha and thromboxane B-2 levels mere
determined to evaluate their role as predictive indicators for the dev
elopment and progression of coronary atherosclerosis in young hypercho
lesterolemic swine. 32 young swine were randomly assigned to the contr
ol or atherogenic diet group for 10, 30, 90, or 180 days. Lipid profil
es were obtained at the onset and repeated throughout the study. Radio
immunoassays of plasma 6-keto-prostaglandin F-1 alpha and thromboxane
B-2 were recorded at 10 day intervals in the 10 and 30 day subjects an
d at 30 day intervals in the 90 and 180 day subjects. Sections from th
e proximal left anterior descending coronary artery were classified ba
sed on their histological evidence of atherosclerosis by light microsc
opy. Hypercholesterolemia was positively correlated with development o
f coronary atherosclerosis (r = 0.704). However, plasma 6-keto-prostag
landin F-1 alpha, thromboxane B-2, and the thromboxane B-2:6-keto-pros
taglandin F-1 alpha ratio were not found to be predictive indicators (
p > 0.05) for the development or early progression of coronary atheros
clerosis.